Prognostic value of esophageal cancer immune prognostic index in advanced esophageal squamous cell carcinoma patients with anti‐programmed cell death‐1 therapy

BACKGROUND: This study aimed to determine whether the immune prognostic index (ECIPI), based on hemoglobin (Hb) and neutrophil‐to‐lymphocyte ratio (NLR), could predict the prognosis in patients with advanced esophageal squamous cell carcinoma (ESCC) receiving programmed cell death‐1 (PD‐1) inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Jiangyue, Du, Lehui, Lei, Xiao, Zhang, Zhibo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242341/
https://www.ncbi.nlm.nih.gov/pubmed/36951584
http://dx.doi.org/10.1002/cam4.5844

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242341/
https://www.ncbi.nlm.nih.gov/pubmed/36951584
http://dx.doi.org/10.1002/cam4.5844

Ejemplares similares